🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

23 recruiting trials

for Colorectal Adenocarcinoma Metastatic in the Liver

The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors NCT07159048NA1 site📍 Shanghai Fudan University · Tests: Multimodal Tumor Thermal Therapy System, Radiofrequency Ablation System or Microwave Ablation System IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors NCT07376707Phase 11 site📍 Shanghai Hefei TG ImmunoPharma Co., Ltd. · Tests: TGI-5 The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. NCT07224464NA1 site📍 Rochester New Phase Ltd. · Tests: The Sarah Nanotechnology System - intended to deliver thermal energy to malignant cells for the purpose of thermal dest… TARGETed Therapy Drug MONITOring in DIGestive Oncology NCT05443087NA29 sites📍 Amiens📍 Auxerre📍 Avignon UNICANCER · Tests: Blood sampling to build population pharmacokinetics model Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers NCT04221893NA2 sites📍 San Francisco📍 Walnut Creek University of California, San Francisco · Tests: Radiation Therapy (RT) First in Human Study of SIM0610 in Solid Tumors NCT07348211Phase 17 sites📍 Chongqing📍 Harbin📍 Shenyang Jiangsu Simcere Pharmaceutical Co., Ltd. · Tests: SIM0610 for Injection, SIM0610 for Injection PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma NCT05286814Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Dexamethasone, PDS01ADC, Intera 3000 Hepatic Artery Infusion Pump (HAIP), Floxuridine Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation NCT04668872n/a1 site📍 New York Memorial Sloan Kettering Cancer Center · Tests: Y90 TARE, PET/CT, PET/MRI ctDNA Monitoring in Patients With HCC and mCRC NCT07001085NA1 site📍 Warsaw Medical University of Warsaw · Tests: Tumor Tissue Collection and NGS, Blood Collection for Plasma ctDNA, ctDNA Mutation Analysis via ddPCR Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases NCT02185443Phase 21 site📍 São Paulo University of Sao Paulo · Tests: SBRT Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors NCT05176483Phase 1122 sites📍 Phoenix📍 Tucson📍 Palo Alto Exelixis · Tests: Zanzalintinib, Nivolumab, Ipilimumab, Nivolumab + Relatlimab, Prednisone Early Detection of Advanced Adenomas and Colorectal Cancer NCT06342440n/a6 sites📍 Monrovia📍 San Diego📍 Dalian City of Hope Medical Center · Tests: DENEB A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis NCT05186116NA1 site📍 Modena Azienda Ospedaliero-Universitaria di Modena · Tests: Living donor liver transplant, Split liver transplant, RAPID, DDLT Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma NCT07082439Phase 21 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Pembrolizumab, Odetiglucan A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site📍 Jacksonville Mayo Clinic · Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Hepatic Arterial Infusion Chemotherapy in Patients With Inoperable Colorectal Cancer Liver Metastasis NCT07764497Phase 21 site📍 Toronto Sunnybrook Health Sciences Centre · Tests: Floxuridine (FUDR) A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors NCT07623369Phase 13 sites📍 Waratah📍 Southport📍 Jinan Huahui Health · Tests: HH160 SL-28 for Advanced Solid Tumours NCT07341737Phase 1, Phase 23 sites📍 Sydney📍 Gold Coast📍 Adelaide Second Life Therapeutics · Tests: SL-28, SL-28, SL-28 A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) NCT05824975Phase 1, Phase 211 sites📍 Scottsdale📍 Jacksonville📍 Rochester GI Innovation, Inc. · Tests: GI-102 subcutaneous (SC), GI-102, doxorubicin, paclitaxel, bevacizumab A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors NCT07636785Phase 1, Phase 21 site📍 Scottsdale VM Discovery, Inc. · Tests: VMD-102
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy